Intercytex hair multiplication results - yr ended Dec 31, 2007

Stem cell; cell based hair therapy
41

i cant understand y u people r moaning

cant u see what this means ??

it means we will c TRC after or during phase II

The barrier to commercial success for ICX-TRC is relatively low, being the ability to increase hair count in transplanted or thinning areas.

42

I also believe they have to proceed in this way becuase of Bosley’s option. In the purchased option, Bosley must be given first rights after successful completion of Phase II. This is exactly what they are doing.

43

Let me quote Nervx first:

"READ PEOPLE. it doesnt say that it has failed. intercytex says they’re getting increased hair counts so how is that bad? they also say barrier
to commercial success is low which is a positive thing… it means low risk of failure if brought to market.

they also didn’t say they are quiting after phase II but looking for a partner to help fund phase III and so on. phase III is on a mass scale, most likely costly and if you remember intercytex was in need of funding before so they likely can’t finish it on their own. maybe some of you should hold out until they release actual information on how the product performs before thinking the world is over and slitting your wrists."

Guys, all FIVE MEN who had their scalp “pre-stimulated” (maybe something like Follica, maybe not, who knows) had increased haircounts…and the three of the five that they were able to check at 24 weeks (6 months) also had increased haircounts, and the two they couldn’t get in the clinic almost assuredly did to.

All this shows is that PRE-STIMULATION really helps the procedure along. They were only getting 50% success without pre-stimulation, but appear to be having 100% success with it. Its hard to believe that “out there in the world” this would not translate into at least --some-- success for anyone who had the procedure done once or twice at the most.

In short my friends…we have a hair grower!It grows hair—whether by revitilization or de noveau hair growth I dont know, but its from taking cells from the donor area and injecting them after multiplication to balding scalp, so its very different than minoxidil or finasteride…Its inejecting donor area genetics into recipient area hair, producing increased hair counts. My one word of caution is…how MUCH more hair did they grow? That is the big question. I wish they put up pictures for us and am going to email them asking for them (but dont expect anything in response).

MORE GOOD NEWS…You guys can be on finasteride, the trialees were NOT ON FINASTERIDE. In other words, your results whether be it on fluridil, finasteride, revivogen, tricomin, AJSC-9 or whatever will almost assuredly be BETTER than the trialees…

MORE GOOD NEWS STILL…nobody said you only have to get TRC ONE TIME…you could get it, and a year or so later…get it again and see if it thickens up even more.

This is not bad news folks. The product worked in all men with pre-stimulated scalps and increased hair counts. They may not turn you into David Beckham overnight, but with ensuing sessions, maybe they can.

About further research…they are selling their research to Aderans (Bosley) in all probability or offering for someone (Aderans) to help fund their phase 3 trial and perhaps come in and help them with it. If Aderans thinks they can improve the procedure, they will attempt it. ICX obviously believes the product they have is sellable RIGHT NOW as it is. ICX, being a small company and very cash poor, isn’t in the position to do a phase three trial ALONE unless they can borrow alot of money to do so (we are talking about nearly a hundred million dollars). Why would they do that if they feel like what they have beats anything else (finasteride and minoxidil and a HT all together) now? They dont, hence they are willing to cash out and sell it to Aderans now.

The only bad news will be if Aderans doesnt buy it or isn’t willing to help fund or partner with ICX for furhter trials. If Aderans just puts it down and doesn nothing, in which case everyone has a right to be pissed off. Im betting that in a few weeks, we will hear that negotiations are taking place between Aderans and ICX for purchace of TRC or sponsorship of their trials or a partnership in a more extensive phase three trial. WHat I really hope to see is that Aderans feels this product is marketable and Bosley will be offering it soon…

Follica will be the “competitor” if their procedure works in the future, probably sold at dermatologists offices.

44

i cant c y aderans wouldnt want to sell TRC having already made a number of milestone payments to intercytex, im sure there will be plenty of other takers

i cant stop looking at page 29 and the small bottle of TRC, its amazing something that looks like water grows hair

45

This is true benji, they have not failed and are still pursing phase II to finish it up and sell it. I think people really need to look at what happened with ICX-PRO. They tried running ICX-PRO phase III on a shoe string budget the first time and the FDA slapped and told them to get more trialists. They don’t have much money to begin with so I mean in a sense its no surprise. Phase III is the most expensive phase to do and if they can’t skip phase III and go to market then as we see they are screwed. So I think we need to hope that someone properly funds them to complete a phase III and markets it relatively soon.

If ICX-TRC does in fact continue on to market it won’t be here till at least 2011-2012.

46

Ok Guys,

I really dont get how some guys misunderstood the whole post…

We believe the continued development of ICX-TRC would best be carried out in partnership with a specialist in the aesthetics field DOES THIS RING THE BELL???.
We do not intend to finance the continuation of clinical and commercial development of ICX-TRC beyond the current Phase II trial and shall seek to sign a partner when we have the complete data package from this trial. Intercytex has granted Bosley, the largest chain of hair transplant clinics in the US, an option to negotiate distribution rights to the product.

DOES THE ABOVE SAYS SOME HOW THAT PHASE III WILL BE HELD WHILE ON SMALL SCALE COMMERCIALIZATION???

47

“Stimulation” is part of the caramilk secret. This is what they will have patented. All of those patients who received the caramilk secret before injections grew more hair, hence the low risk rating for profit maximization. Sounds like Bosley has a certain pre-arrangement to capitalize on this one.

» So 2 of the 6 patients without stimulation LOST hair. It makes you wonder
» if there’s more value to the stimulation than the actual cell injections.
» It also makes you wonder if Follica is onto something.
»
»
»
»
» .

48

» “Stimulation” is part of the caramilk secret. This is what they will have
» patented. All of those patients who received the caramilk secret before
» injections grew more hair, hence the low risk rating for profit
» maximization. Sounds like Bosley has a certain pre-arrangement to
» capitalize on this one.
»
»
» » So 2 of the 6 patients without stimulation LOST hair. It makes you
» wonder
» » if there’s more value to the stimulation than the actual cell
» injections.
» » It also makes you wonder if Follica is onto something.

Speaking of Aderans, they are supposed to be coming out with there financial statement for 2007 anytime soon with a projection for their HM.